Murphy Pohlad Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.64M Sell
11,109
-540
-5% -$112K 0.92% 43
2026
Q1
$2.46M Sell
11,649
-56
-0.5% -$12.1K 0.88% 45
2025
Q4
$2.41M Hold
11,705
0.92% 44
2025
Q3
$1.84M Hold
11,705
0.72% 50
2025
Q2
$1.97M Hold
11,705
0.83% 48
2025
Q1
$1.61M Hold
11,705
0.68% 54
2024
Q4
$1.38M Hold
11,705
0.6% 59
2024
Q3
$1.29M Sell
11,705
-580
-5% -$60.6K 0.54% 62
2024
Q2
$1.21M Buy
+12,285
New +$1.25M 0.52% 61

Other funds holding CAH

Murphy Pohlad Asset Management's CAH Position: Q2 2026 in Review

Murphy Pohlad Asset Management reduced its Cardinal Health (CAH) stake by 4.6% in Q2 2026, selling an estimated $112K and leaving 11,109 shares worth $2.64M. The position accounts for 0.92% of the portfolio, ranked #43.

Murphy Pohlad Asset Management first reported a position in CAH in Q2 2024 and has held it in 9 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Murphy Pohlad Asset Management held 11,109 shares of Cardinal Health worth $2.64M as of Q2 2026.
  • Murphy Pohlad Asset Management sold 540 Cardinal Health shares in Q2 2026, an estimated $112K.
  • Cardinal Health made up 0.92% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #43 holding.
  • Murphy Pohlad Asset Management first reported a position in Cardinal Health in Q2 2024 and has held it in 9 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.